The global infectious disease testing kits market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of infectious diseases and the need for accurate diagnosis. The molecular diagnostic test segment accounted for the largest share in 2018, followed by POCT and immunodiagnostic tests. Molecular diagnostic tests are used for HIV, respiratory, HAIs, sexual health and tropical diseases whereas POCT is used for HIV and respiratory infections. North America accounted for the largest share in 2018 due to high prevalence of infectious diseases such as HIV/AIDS and hepatitis C virus (HCV) in this region.
Some Of The Growth Factors Of This Market:
- The increasing number of infectious diseases and the need for rapid diagnosis.
- The growing demand for point-of-care testing kits.
- The increasing number of emerging markets in developing countries.
- The development of new technologies to improve the accuracy and sensitivity of tests.
- Increasing government funding.
Industry Growth Insights published a new data on “Infectious Disease Testing Kits Market”. The research report is titled “Infectious Disease Testing Kits Market research by Types (Molecular diagnostic test, POCT, Immunodiagnostic test), By Applications (HIV, Respiratory, HAIs, Sexual health, Tropical diseases, Hepatitis), By Players/Companies Abbott Diagnostics, Alere, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies , Maxim Biomedical, Mindray, OraSure Technologies, Ortho Clinical Diagnostics, Quidel Corporation, Thermo Fisher Scientific , Trinity Biotech”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Infectious Disease Testing Kits Market Research Report
By Type
Molecular diagnostic test, POCT, Immunodiagnostic test
By Application
HIV, Respiratory, HAIs, Sexual health, Tropical diseases, Hepatitis
By Companies
Abbott Diagnostics, Alere, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies , Maxim Biomedical, Mindray, OraSure Technologies, Ortho Clinical Diagnostics, Quidel Corporation, Thermo Fisher Scientific , Trinity Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Infectious Disease Testing Kits Market Report Segments:
The global Infectious Disease Testing Kits market is segmented on the basis of:
Types
Molecular diagnostic test, POCT, Immunodiagnostic test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
HIV, Respiratory, HAIs, Sexual health, Tropical diseases, Hepatitis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Diagnostics
- Alere
- Beckman Coulter Diagnostics
- Roche
- Siemens Healthcare
- Abaxis
- Acon Laboratories
- Avioq
- BD
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Chembio Diagnostic Systems
- Clarity Diagnostics
- EMD Millipore
- Epitope Diagnostic
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
- Life TechnologiesÂ
- Maxim Biomedical
- Mindray
- OraSure Technologies
- Ortho Clinical Diagnostics
- Quidel Corporation
- Thermo Fisher ScientificÂ
- Trinity Biotech
Highlights of The Infectious Disease Testing Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Molecular diagnostic test
- POCT
- Immunodiagnostic test
- By Application:
- HIV
- Respiratory
- HAIs
- Sexual health
- Tropical diseases
- Hepatitis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infectious Disease Testing Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infectious Disease Testing Kits are used to test for the presence of specific infections. They can be used to screen for diseases such as tuberculosis, HIV, and hepatitis.
Some of the key players operating in the infectious disease testing kits market are Abbott Diagnostics, Alere, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies‚Â , Maxim Biomedical, Mindray, OraSure Technologies, Ortho Clinical Diagnostics, Quidel Corporation, Thermo Fisher Scientific‚Â , Trinity Biotech.
The infectious disease testing kits market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Infectious Disease Testing Kits Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Infectious Disease Testing Kits Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Infectious Disease Testing Kits Market - Supply Chain
4.5. Global Infectious Disease Testing Kits Market Forecast
4.5.1. Infectious Disease Testing Kits Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Infectious Disease Testing Kits Market Size (000 Units) and Y-o-Y Growth
4.5.3. Infectious Disease Testing Kits Market Absolute $ Opportunity
5. Global Infectious Disease Testing Kits Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Infectious Disease Testing Kits Market Size and Volume Forecast by Type
5.3.1. Molecular diagnostic test
5.3.2. POCT
5.3.3. Immunodiagnostic test
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Infectious Disease Testing Kits Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Infectious Disease Testing Kits Market Size and Volume Forecast by Application
6.3.1. HIV
6.3.2. Respiratory
6.3.3. HAIs
6.3.4. Sexual health
6.3.5. Tropical diseases
6.3.6. Hepatitis
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Infectious Disease Testing Kits Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Infectious Disease Testing Kits Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Infectious Disease Testing Kits Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Infectious Disease Testing Kits Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Infectious Disease Testing Kits Demand Share Forecast, 2019-2026
9. North America Infectious Disease Testing Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Infectious Disease Testing Kits Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Infectious Disease Testing Kits Market Size and Volume Forecast by Application
9.4.1. HIV
9.4.2. Respiratory
9.4.3. HAIs
9.4.4. Sexual health
9.4.5. Tropical diseases
9.4.6. Hepatitis
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Infectious Disease Testing Kits Market Size and Volume Forecast by Type
9.7.1. Molecular diagnostic test
9.7.2. POCT
9.7.3. Immunodiagnostic test
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Infectious Disease Testing Kits Demand Share Forecast, 2019-2026
10. Latin America Infectious Disease Testing Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Infectious Disease Testing Kits Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Infectious Disease Testing Kits Market Size and Volume Forecast by Application
10.4.1. HIV
10.4.2. Respiratory
10.4.3. HAIs
10.4.4. Sexual health
10.4.5. Tropical diseases
10.4.6. Hepatitis
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Infectious Disease Testing Kits Market Size and Volume Forecast by Type
10.7.1. Molecular diagnostic test
10.7.2. POCT
10.7.3. Immunodiagnostic test
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Infectious Disease Testing Kits Demand Share Forecast, 2019-2026
11. Europe Infectious Disease Testing Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Infectious Disease Testing Kits Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Infectious Disease Testing Kits Market Size and Volume Forecast by Application
11.4.1. HIV
11.4.2. Respiratory
11.4.3. HAIs
11.4.4. Sexual health
11.4.5. Tropical diseases
11.4.6. Hepatitis
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Infectious Disease Testing Kits Market Size and Volume Forecast by Type
11.7.1. Molecular diagnostic test
11.7.2. POCT
11.7.3. Immunodiagnostic test
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Infectious Disease Testing Kits Demand Share, 2019-2026
12. Asia Pacific Infectious Disease Testing Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Infectious Disease Testing Kits Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Infectious Disease Testing Kits Market Size and Volume Forecast by Application
12.4.1. HIV
12.4.2. Respiratory
12.4.3. HAIs
12.4.4. Sexual health
12.4.5. Tropical diseases
12.4.6. Hepatitis
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Infectious Disease Testing Kits Market Size and Volume Forecast by Type
12.7.1. Molecular diagnostic test
12.7.2. POCT
12.7.3. Immunodiagnostic test
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Infectious Disease Testing Kits Demand Share, 2019-2026
13. Middle East & Africa Infectious Disease Testing Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Infectious Disease Testing Kits Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Infectious Disease Testing Kits Market Size and Volume Forecast by Application
13.4.1. HIV
13.4.2. Respiratory
13.4.3. HAIs
13.4.4. Sexual health
13.4.5. Tropical diseases
13.4.6. Hepatitis
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Infectious Disease Testing Kits Market Size and Volume Forecast by Type
13.7.1. Molecular diagnostic test
13.7.2. POCT
13.7.3. Immunodiagnostic test
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Infectious Disease Testing Kits Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Infectious Disease Testing Kits Market: Market Share Analysis
14.2. Infectious Disease Testing Kits Distributors and Customers
14.3. Infectious Disease Testing Kits Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Diagnostics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alere
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Beckman Coulter Diagnostics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Siemens Healthcare
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Abaxis
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Acon Laboratories
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Avioq
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BD
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bio-Rad Laboratories
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cavidi
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Cepheid
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Chembio Diagnostic Systems
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Clarity Diagnostics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. EMD Millipore
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Epitope Diagnostic
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Gold Standard Diagnostics
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Hologic
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Immunetics
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. InBios International
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
